FDA advisory group rejects Covid boosters for most, limits to high-risk groups

FDA advisory group rejects Covid boosters for most, limits to high-risk groups

The FDA’s advisory committee voted in favor Covid-19 vaccine booster shots for older adults and those at high risk.